21 related articles for article (PubMed ID: 32319393)
1. Ribonucleotide reductase subunit switching in hepatoblastoma drug response and relapse.
Brown A; Pan Q; Fan L; Indersie E; Tian C; Timchenko N; Li L; Hansen BS; Tan H; Lu M; Peng J; Pruett-Miller SM; Yu J; Cairo S; Zhu L
Commun Biol; 2023 Mar; 6(1):249. PubMed ID: 36882565
[TBL] [Abstract][Full Text] [Related]
2. Retraction notice to Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase (RRM2): a novel therapeutic strategy in pancreatic cancer [Surgery 136 (2004) 261-269].
Duxbury MS; Ito H; Benoit E; Zinner MJ; Ashley SW; Whang EE
Surgery; 2023 Apr; 173(4):1109. PubMed ID: 36774320
[No Abstract] [Full Text] [Related]
3. A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors.
Li Y; Fu W; Geng Z; Song Y; Yang X; He T; Wu J; Wang B
PeerJ; 2022; 10():e14432. PubMed ID: 36518297
[TBL] [Abstract][Full Text] [Related]
4. Silencing RRM2 inhibits multiple myeloma by targeting the Wnt/β‑catenin signaling pathway.
Liu X; Peng J; Zhou Y; Xie B; Wang J
Mol Med Rep; 2019 Sep; 20(3):2159-2166. PubMed ID: 31322175
[TBL] [Abstract][Full Text] [Related]
5. Small interfering RNA (siRNA)-mediated silencing of the M2 subunit of ribonucleotide reductase: a novel therapeutic strategy in ovarian cancer.
Zhang M; Wang J; Yao R; Wang L
Int J Gynecol Cancer; 2013 May; 23(4):659-66. PubMed ID: 23466567
[TBL] [Abstract][Full Text] [Related]
6. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
[TBL] [Abstract][Full Text] [Related]
7. Emerging roles of the ribonucleotide reductase M2 in colorectal cancer and ultraviolet-induced DNA damage repair.
Lu AG; Feng H; Wang PX; Han DP; Chen XH; Zheng MH
World J Gastroenterol; 2012 Sep; 18(34):4704-13. PubMed ID: 23002339
[TBL] [Abstract][Full Text] [Related]
8. [SATB1 promotes the malignant of human non-Hodgkin lymphoma by activating the ribonucleotide reductase
small subunit M2].
Yan D; Wang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1155-1162. PubMed ID: 27932760
[TBL] [Abstract][Full Text] [Related]
9. Cancer Fighting SiRNA-RRM2 Loaded Nanorobots.
Sharma A; Kumar P; Ambasta RK
Pharm Nanotechnol; 2020; 8(2):79-90. PubMed ID: 32003677
[TBL] [Abstract][Full Text] [Related]
10. Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer.
Zuo Z; Zhou Z; Chang Y; Liu Y; Shen Y; Li Q; Zhang L
Genes Dis; 2024 Jan; 11(1):218-233. PubMed ID: 37588202
[TBL] [Abstract][Full Text] [Related]
11. [Expression of Ribonucleotide Reductase M2 in Patients with Multiple Myeloma and Its Mechanism Inhibiting Tumor Cell Proliferation].
Liu X; Chen L; Fan LP; Cheng Z
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):540-546. PubMed ID: 32319393
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
